Stimulants, which are the most commonly used form of medication, increase the neurotransmitter, dopamine levels in the brain that are involved in the activation of attention, motivation, and movement. An alternative for children unable to tolerate the administration of Stimulants is Non-Stimulants approved by the FDA, such as Strattera (atomoxetine), Intuniv (guanfacine), and Kapvay (clonidine) (http://www.fda.gov/downloads/ForConsumers/ConsumerUpdates/UCM279341.pdf).
Quick Facts
• Attention Deficit/Hyperactivity Disorder, commonly known as ADHD, is one of the most prevalent neurobehavioral disorders that impacts children and adults.
• At least one third of the children diagnosed with ADHD will continue to endure problems into adulthood.
• Center for Disease Control (CDC) estimates that one in ten children that are four to seventeen years of age have been diagnosed with ADHD in the United States.
• A combination of behavior therapy, well-balanced diet, and medications are recommended in the treatment of ADHD.
• A conservative estimate places the total cost of treating Attention Deficit/Hyperactivity Disorder at $38